{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:25:23Z","timestamp":1773332723295,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["23\/447"],"award-info":[{"award-number":["23\/447"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.lungcan.2025.108761","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:16:39Z","timestamp":1758575799000},"page":"108761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Patterns of treatment prior to death among those with lung cancer: A national study in a universal healthcare context"],"prefix":"10.1016","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7615-0748","authenticated-orcid":false,"given":"J.","family":"Gurney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4723-618X","authenticated-orcid":false,"given":"D.","family":"Ongley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0572-1715","authenticated-orcid":false,"given":"S.","family":"Costello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7057-1480","authenticated-orcid":false,"given":"A.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6150-709X","authenticated-orcid":false,"given":"C.G.C.A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Koea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2025.108761_b0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1200\/GO.20.00028","article-title":"Disparities in Cancer-specific Survival between M\u0101ori and Non-M\u0101ori New Zealanders, 2007-2016","volume":"6","author":"Gurney","year":"2020","journal-title":"JCO Global Oncology"},{"issue":"10299","key":"10.1016\/j.lungcan.2025.108761_b0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lungcan.2025.108761_b0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.5436","article-title":"Contemporary patterns of End-of-Life Care among Medicare Beneficiaries with Advanced Cancer","volume":"6","author":"Kwon","year":"2025","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.lungcan.2025.108761_b0020","doi-asserted-by":"crossref","unstructured":"Ullgren H, Fransson P, Olofsson A, et al. Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts. PLoS ONE 2021;16(7 July) doi: 10.1371\/journal.pone.0254673.","DOI":"10.1371\/journal.pone.0254673"},{"issue":"8","key":"10.1016\/j.lungcan.2025.108761_b0025","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00432-018-2673-x","article-title":"End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer","volume":"144","author":"Zhu","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.lungcan.2025.108761_b0030","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1002\/cncr.31536","article-title":"Timing of palliative care needs reporting and aggressiveness of care near the end of life in metastatic lung cancer: a national registry-based study","volume":"124","author":"Goldwasser","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2025.108761_b0035","unstructured":"O. Te Aho T.e. Kahu -. Cancer Control Agency. Lung Cancer Quality Improvement Monitoring Report, Wellington 2021 Te Aho o Te Kahu - Cancer Control Agency New Zealand 2021."},{"issue":"12","key":"10.1016\/j.lungcan.2025.108761_b0040","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/sj.bjc.6603498","article-title":"Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients","volume":"95","author":"O'Brien","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lungcan.2025.108761_b0045","unstructured":"N.Z.H.I. Service Ministry of Health. New Zealand Cancer Registry Data Dictionary 2004 Wellington, New Zealand."},{"issue":"S2","key":"10.1016\/j.lungcan.2025.108761_b0050","first-page":"S7","article-title":"Development of New Zealand\u2019s Deprivation Index (NZDep) and its uptake as a national policy tool","volume":"103","author":"Salmond","year":"2012","journal-title":"Can. J. Public Health"},{"key":"10.1016\/j.lungcan.2025.108761_b0055","doi-asserted-by":"crossref","unstructured":"Whitehead J, Davie G, de Graaf B, et al. Defining rural in Aotearoa New Zealand: a novel geographic classification for health purposes. N Z Med J 2022;135(1559):24-40. [published Online First: 2022\/08\/25].","DOI":"10.26635\/6965.5495"},{"key":"10.1016\/j.lungcan.2025.108761_b0060","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jclinepi.2013.11.012","article-title":"Cancer-specific administrative data-based comorbidity indices provided valid alternative to Charlson and NHI indices","volume":"67","author":"Sarfati","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.lungcan.2025.108761_b0065","unstructured":"J. Young F. Roffers L. Gloeckler Ries et al. SEER Summary Staging Manual - 2000: Codes and Coding Instructions 2000 Bethesda, MD National Cancer Institute."},{"issue":"9","key":"10.1016\/j.lungcan.2025.108761_b0070","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/bjc.2015.355","article-title":"The impact of patient comorbidity on cancer stage at diagnosis","volume":"113","author":"Gurney","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lungcan.2025.108761_b0075","first-page":"43","article-title":"Stage at diagnosis for Maori cancer patients: disparities, similarities and data limitations","volume":"133","author":"Gurney","year":"2020","journal-title":"N. Z. Med. J."},{"key":"10.1016\/j.lungcan.2025.108761_b0080","article-title":"Access to and Timeliness of Lung Cancer Surgery, Radiation Therapy, and Systemic Therapy in New Zealand: a Universal Health Care Context","volume":"10","author":"Gurney","year":"2024","journal-title":"JCO Global Oncology"},{"issue":"3","key":"10.1016\/j.lungcan.2025.108761_b0085","first-page":"1","article-title":"Age standardisation - an idigenous standard?","volume":"4","author":"Robson","year":"2007","journal-title":"Emerg. Themes Epidemiol."},{"issue":"2","key":"10.1016\/j.lungcan.2025.108761_b0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.prro.2011.01.005","article-title":"Palliative thoracic radiotherapy in lung cancer: an American Society for Radiation Oncology evidence-based clinical practice guideline","volume":"1","author":"Rodrigues","year":"2011","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.lungcan.2025.108761_b0095","doi-asserted-by":"crossref","unstructured":"Davies A, Stanley J, Costello S, et al. Radiation therapy for lung cancer in Aotearoa New Zealand. Cancer Causes and Control 2025;Under review.","DOI":"10.1007\/s10552-025-02052-w"},{"issue":"22","key":"10.1016\/j.lungcan.2025.108761_b0100","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1001\/jama.299.22.2667","article-title":"The role of chemotherapy at the end of life: \u201cwhen is enough, enough?\u201d","volume":"299","author":"Harrington","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.lungcan.2025.108761_b0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lungcan.2019.06.003","article-title":"Factors associated with early mortality in non-small cell lung cancer patients following systemic anti-cancer therapy: a 10 year population-based study","volume":"134","author":"Gibson","year":"2019","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.lungcan.2025.108761_b0110","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S1470-2045(16)30383-7","article-title":"30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study","volume":"17","author":"Wallington","year":"2016","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2025.108761_b0115","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00030-2018","article-title":"30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?","volume":"4","author":"Burgers","year":"2018","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.lungcan.2025.108761_b0120","unstructured":"O. Te Aho T.e. Kahu -. Cancer Control Agency. He P\u016brongo Mate Pukupuku o Aotearoa, The State of Cancer in New Zealand 2020 2020 Te Aho o Te Kahu - Cancer Control Agency Wellington, New Zealand 2021."},{"issue":"7","key":"10.1016\/j.lungcan.2025.108761_b0125","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Small-cell lung cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up(\u2606)","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2025.108761_b0130","unstructured":"United Nations. World Population Dashboard. 2022."},{"key":"10.1016\/j.lungcan.2025.108761_b0135","unstructured":"Te Aho O Te Kahu - Cancer Control Agency. The ACT-NOW Programme Wellington, New Zealand: Te Aho o Te Kahu - Cancer Control Agency; 2021 [Available from: https:\/\/teaho.govt.nz\/index.php\/our-work\/canshare\/act-now-programme."},{"issue":"3","key":"10.1016\/j.lungcan.2025.108761_b0140","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41416-025-03071-9","article-title":"National variation in the treatment of lung cancer in a universal healthcare context","volume":"133","author":"Gurney","year":"2025","journal-title":"Br. J. Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500225006531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:28:24Z","timestamp":1773289704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500225006531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"alternative-id":["S0169500225006531"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108761","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of treatment prior to death among those with lung cancer: A national study in a universal healthcare context","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2025.108761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108761"}}